tiprankstipranks
Trending News
More News >
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Income Statement

Compare
259 Followers

Lantern Pharma Income Statement

Last quarter (Q3 2024), Lantern Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lantern Pharma's net income was $-4.51M. See Lantern Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -174.84K$ -154.68K$ -97.42K$ -3.39K
Operating Expenses
$ 22.22B$ 17.88M$ 14.43M$ 12.59M$ 5.91M
Depreciation and Amortization
$ 0.00$ 174.84K$ 154.68K$ 97.42K$ 3.39K
EBITDA
$ -22.22B$ -15.79M$ -14.42M$ -12.27M$ -5.90M
Operating Income
$ -22.22B$ -17.88M$ -14.43M$ -12.59M$ -5.91M
Other Income/Expenses
$ 1.44B$ 1.92M$ 172.81K$ 228.48K$ 0.00
Pretax Income
$ -20.78B$ -15.96M$ -14.26M$ -12.36M$ -5.91M
Net Income
$ -20.78B$ -15.96M$ -14.09M$ -12.30M$ -5.91M
Per Share Metrics
Basic EPS
$ -1.93K$ -1.47$ -1.30$ -1.13$ -0.95
Diluted EPS
$ -1.93K$ -1.47$ -1.30$ -1.13$ -0.95
Weighted Average Shares Outstanding
10.76M 10.84M 10.85M 10.90M 6.22M
Weighted Average Shares Outstanding (Diluted)
10.76M 10.84M 10.85M 10.90M 6.22M
Currency in USD

Lantern Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis